Metabolic Syndrome Cluster Does Not Provide Incremental Prognostic Information in Patients with Stable Cardiovascular Disease: A Post Hoc Analysis of the AIM-HIGH trial

BACKGROUND: Metabolic syndrome (MS) is a well-known risk factor for the development of cardiovascular (CV) disease, yet controversy persists whether it adds incremental prognostic value in patients with established CV disease. OBJECTIVES: This study was performed to determine if MS is associated wit...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Lipidol
Egile Nagusiak: Lyubarova, Radmila, Robinson, Jennifer G., Miller, Michael, Simmons, Debra L., Xu, Ping, Abramson, Beth L., Elam, Marshall B., Brown, Todd M., McBride, Ruth, Fleg, Jerome L., Desvigne-Nickens, Patrice, Ayenew, Woubeshet, Boden, William E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5612889/
https://ncbi.nlm.nih.gov/pubmed/28807460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacl.2017.06.017
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak